0001973379-24-000085.txt : 20240304 0001973379-24-000085.hdr.sgml : 20240304 20240304143616 ACCESSION NUMBER: 0001973379-24-000085 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240304 DATE AS OF CHANGE: 20240304 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Ascendis Pharma A/S CENTRAL INDEX KEY: 0001612042 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: G7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-36815 FILM NUMBER: 24714432 BUSINESS ADDRESS: STREET 1: TUBORG BOULEVARD 12 CITY: HELLERUP STATE: G7 ZIP: DK-2900 BUSINESS PHONE: 45 70 22 22 44 MAIL ADDRESS: STREET 1: TUBORG BOULEVARD 12 CITY: HELLERUP STATE: G7 ZIP: DK-2900 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: SMITH SCOTT THOMAS CENTRAL INDEX KEY: 0001965550 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O ASCENDIS PHARMA A/S STREET 2: TUBORG BOULEVARD 12 CITY: HELLERUP STATE: G7 ZIP: DK-2900 144 1 primary_doc.xml 144 0001965550 XXXXXXXX LIVE 0001612042 Ascendis Pharma A/S 001-36815 TUBORG BOULEVARD 12 HELLERUP G7 DK-2900 45 70 22 22 44 SMITH SCOTT THOMAS Officer Chief Financial Officer Ordinary Shares Georgeson Securities Corp

144 Fernwood Avenue Edison NJ 08837

6900 1035000.00 57707439 03/01/2024 NASDAQ Ordinary Shares 03/01/2024 Restricted Stock Vesting Ascendis Pharma A/S N 6900 03/01/2024 Services Rendered N Scott Thomas Smith

c/o Tuborg Blvd 12 Hellerup G7 DK-2900

Ordinary Shares 02/16/2024 6563 978100.27 The sales were completed according to 10B5-1 plans entered into in September 2023, for the sale of shares in connection to RSUs and PSUs vesting. 03/04/2024 Conformed Signature on File